PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
PANTOPRAZOLE SODIUM
Approval overview PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 217512 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PANTOPRAZOLE SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 40MG BASE/100ML (EQ 0.4MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2024-02-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 217512 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PANTOPRAZOLE SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 40MG BASE/100ML (EQ 0.4MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2024-02-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.